Keros Therapeutics Inc Shares Near 52-Week Low - Market Mover
The shares closed 1.5% above its 52-week low of $30.28, with trading volume higher than its 30 day average
Sep 18, 2021 by Kwhen Finance Editors
Keros Therapeutics Inc (KROS) shares closed today at 1.5% above its 52 week low of $30.28, giving the company a market cap of $726M. The stock is currently down 55.9% year-to-date, down 32.0% over the past 12 months, and up 55.0% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.4%.
Trading Activity
- Trading volume this week was 47.4% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates an upward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
- The stock closed at 1.3% lower than its 5-day moving average, 5.8% lower than its 20-day moving average, and 25.2% lower than its 90-day moving average.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Keros Therapeutics Inc | -1.3 | -55.9 | -32.0 | -64.7 | 3.4 |
| Dow Jones Industrial Average | -0.7 | 15.1 | 26.1 | -2.6 | 34.6 |
| S&P 500 Index | -1.3 | 20.4 | 33.9 | -2.0 | 40.6 |
| Health Care | 0.1 | 17.5 | 27.3 | -3.1 | 33.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 118.6%
- The company's stock price performance over the past 12 months lags the peer average by 186.2%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | KROS | 0 | -55.9 | -32.0 | -64.7 | 3.4 |
| Peer Avg | N/A | 0 | -25.6 | -11.2 | -28.3 | 26.9 |
| ORIC Pharmaceuticals Inc | ORIC | 0 | -27.4 | 12.2 | -36.1 | 66.4 |
| Otonomy Inc | OTIC | 0 | -74.8 | -57.0 | -76.9 | 41.2 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: